Meta Pixel

News and Announcements

Thinxtra Releases the Xkit, calling it “the Most Versatile Sigfox”

  • Published April 14, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Thinxtra is proud to announce the launch of the Xkit – an Arduino based development platform for the Sigfox global network. The perfect way to get started with Sigfox, the Thinxtra Xkit devkit boasts a full suite of features and accessories to empower anyone to set up an IoT solution, even with very little hardware experience.

KEY TAKEAWAYS:

  • Perfect for start-ups, design houses, universities and schools, the kit has everything needed to hit the ground running using the globally available Sigfox network.
  • The Xkit supports multiple hardware development platforms to enable discovery and development at varying levels of technical skills.
  • The shield can be used with Arduino Uno R3 board clone (included), STM Nucleo development board, Freescale development board, and Microchip development kit.
  • The shield, via its USB port, can also be plugged into Raspberry Pi, PC and Mac computers.
  • Thinxtra also provides complete step-by-step guides to use the Xkit with well known IoT platforms: Amazon Web Services IoT, Microsoft Azure and IBM Bluemix.

The Xkit is now available for purchase and supports three Sigfox zones:

RCZ1 – Europe

RCZ2 – US, Mexico and Brasil

RCZ4 – Australia, New Zealand, Asia and Latin America

Renald Gallis, VP Marketing and Ecosystem at Thinxtra: “We realised early in the game that the best way to support the ecosystem is by creating a truly low cost, versatile and powerful development kit. This aligns with the Sigfox value proposition: low cost, simple and streamlined connectivity. The simplicity is further enhanced via our easy 4-step set up process which allows users to register online and get immediate access to a year of free Sigfox connectivity. “

The Xkit will be presented and demonstrated by Kade Miller at Kydo in Melbourne on May 2nd.

Request Offer

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now